I want to understand my iron levels - is it worth me having an iron transfusion

Imagine your body as a walled city where iron is a precious, yet highly volatile, fuel. If too little enters, the city's engines grind to a halt; if too much floods in, it sparks destructive oxidative fires. The master gatekeeper of this city is **hepcidin**, a tiny peptide hormone produced by the liver. While we often think of iron absorption as a simple function of what we eat, hepcidin acts as a biochemical dimmer switch, constantly adjusting our systemic iron levels in ways that defy simple dietary logic. ## The Cellular Iron Locks and the Hepcidin Key To understand hepcidin, we must meet its target: **ferroportin**. Ferroportin is the only known cellular channel that allows iron to exit cells and enter the bloodstream. It is found on the surface of duodenal enterocytes (gut absorption cells), macrophages (immune cells that recycle old red blood cells), and hepatocytes (liver storage cells). When hepcidin is released into the blood, it acts as a molecular key. It binds to ferroportin, causing the channel to be drawn inside the cell and degraded. As pioneer iron researchers Tomas Ganz and Elizabeta Nemeth note in their seminal work on [Hepcidin and Iron Homeostasis](https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2796.2006.01622.x): > "Hepcidin acts by binding to ferroportin, the sole known iron exporter, inducing its internalization and degradation. This regulatory loop restricts iron entry into the plasma from the three main sources of iron: dietary absorption, recycling of senescent erythrocytes, and mobilization from hepatic stores." Without ferroportin channels on the cell surface, iron becomes trapped inside the gut cells. Because human skin and gut linings shed every few days, this trapped iron is simply sloughed off and lost in the stool, completely bypassing systemic circulation. ## The Irony of Inflammation and the Infection Blockade Why would the body purposefully block its own iron absorption? The answer lies in evolutionary survival. Many pathogens, particularly bacteria, require host iron to replicate. When your immune system detects an infection or chronic inflammation, it releases inflammatory cytokines like Interleukin-6 (IL-6). These cytokines signal the liver to rapidly increase hepcidin production. By shutting down ferroportin, the body actively hides its iron reserves inside macrophages and liver cells, starving the invading pathogens. However, this defense mechanism creates a modern clinical paradox known as the **Anemia of Chronic Disease**. In patients with chronic inflammatory states—such as rheumatoid arthritis, inflammatory bowel disease, or chronic kidney disease—hepcidin remains permanently elevated. Even if these patients take high-dose oral iron supplements, the "gates" remain locked. The iron cannot escape the gut cells, rendering oral supplementation virtually useless and making intravenous bypass the only viable therapeutic option. ## The Counterintuitive Pattern of Alternate-Day Dosing This tight regulatory loop has revolutionized how we approach simple iron deficiency. Historically, doctors prescribed daily, high-dose oral iron. However, recent clinical trials, such as those published in [*The Lancet Haematology*](https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(15)00226-0/fulltext), have revealed a counterintuitive feedback loop. When you ingest a large dose of oral iron, the sudden spike in circulating iron triggers a protective surge of hepcidin that peaks several hours later and lasts for up to 48 hours. If you take another iron pill the very next day, the lingering hepcidin ensures that almost none of it is absorbed, serving only to irritate the gastrointestinal tract. By shifting to **alternate-day dosing** (taking iron every other day), we allow hepcidin levels to fall back to baseline, significantly increasing overall absorption efficiency while drastically reducing side effects. Understanding this molecular gatekeeper transforms how we manage everything from basic fatigue to complex chronic disease.